Asset Allocation

As of June 30, 2026.
Type % Net
Cash 14.07%
Stock 64.44%
Bond 19.06%
Convertible 0.00%
Preferred 0.00%
Other 2.43%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 83.87%    % Emerging Markets: 0.62%    % Unidentified Markets: 15.51%

Americas 53.12%
51.45%
Canada 6.49%
United States 44.96%
1.67%
Mexico 0.58%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 22.42%
United Kingdom 4.23%
17.39%
Belgium 1.60%
Denmark 2.97%
France 3.41%
Ireland 4.07%
Italy 0.49%
Netherlands 2.84%
Spain 0.98%
Switzerland 1.03%
0.00%
0.79%
Israel 0.76%
South Africa 0.03%
Greater Asia 8.95%
Japan 4.75%
1.42%
Australia 1.42%
2.78%
Hong Kong 0.58%
South Korea 2.20%
0.00%
Unidentified Region 15.51%

Bond Credit Quality Exposure

AAA 0.00%
AA 32.72%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 67.28%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
20.76%
Materials
11.51%
Consumer Discretionary
1.06%
Financials
8.19%
Real Estate
0.00%
Sensitive
23.95%
Communication Services
5.08%
Energy
5.25%
Industrials
6.68%
Information Technology
6.93%
Defensive
21.85%
Consumer Staples
4.70%
Health Care
15.14%
Utilities
2.00%
Not Classified
1.04%
Non Classified Equity
1.04%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 99.41%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.59%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
89.75%
Less than 1 Year
89.75%
Intermediate
10.25%
1 to 3 Years
10.25%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial